News

Keep up to date with the latest news items from GAFFI.

Hyper-endemic areas for histoplasmosis revealed in new SE Asian maps

August 6, 2019

Following GAFFI submission WHO endorses Histoplasma antigen as an Essential Diagnostic

July 11, 2019

LDBio rapid Aspergillus IgG test is sensitive and specific for chronic pulmonary aspergillosis

July 5, 2019

Dr Swarup Sarkar joins GAFFI as a Senior Advisor

June 5, 2019

Paracoccidioidomycosis in South America should be a Neglected Fungal Tropical Disease

May 20, 2019

ECCMID 2019 presentations: burden of fungal disease estimates for Namibia, Paraguay and Kyrgyzstan; and fungal keratitis leads to over 600,000 blind eyes annually

April 16, 2019

GAFFI issues its 5th annual report highlighting its extensive advocacy work

April 9, 2019

The Manaus Declaration on Histoplasmosis in the Americas and Caribbean 100 by 2025

March 26, 2019

1 in 15 TB sufferers go on to develop chronic pulmonary aspergillosis, treatment could save 1000s of lives

March 19, 2019

GHANA’S CPA AWARENESS SEMINAR ON WORLD ASPERGILLOSIS DAY

February 11, 2019

GAFFI is the sole organization committed to enhancing the diagnosis, facilitating access to treatment, and improving outcomes in HIV-associated fungal disease.